Free shipping on all orders over $ 500

Mito-Lonidamine

Cat. No. M58968

All AbMole products are for research use only, cannot be used for human consumption.

Mito-Lonidamine Structure
Synonym:

Mito-LND

Size Price Availability Quantity
1mg USD 95 In stock
5mg USD 200 In stock
10mg USD 340 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Mito-Lonidamine (Mito-LND) is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation (OXPHOS). Mito-Lonidamine inhibits mitochondrial bioenergetics, stimulates the formation of reactive oxygen species, and induces autophagic cell death in lung cancer cells.

Mito-LND (7.5 μmol/kg; oral gavage; 5 days per week; for 3 consecutive weeks) significantly decreased tumor progression in athymic nude mice (5 weeks) injected with H2030BrM3 cells.

Chemical Information
Molecular Weight 801.62
Formula C43H45BrCl2N3OP
CAS Number 2361564-49-8
Form Solid
Solubility (25°C) DMSO 45 mg/mL
Storage -20°C, dry, sealed
Related Mitochondrial Related Products
Thiabendazole

Thiabendazole inhibites the mitochondrial helminth-specific enzyme, fumarate reductase, with anthelminthic property.

VLX600

VLX600 is a novel inhibitor of iron-chelated oxidative phosphorylation (OXPHOS). VLX600 causes mitochondrial dysfunction and can show enhanced cytotoxicity in nutrient deficiency conditions. VLX600 showed selective cytotoxic activity against malignant cells and induced autophagy and had anticancer activity.*The compound is unstable in solutions, freshly prepared is recommended

FCCP

FCCP is a mitochondrial uncoupling agent and an oxidative phosphorylation (OXPHOS) inhibitor. FCCP is often used as an apoptosis inducer.

Lixumistat

Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat (IM156) is a metformin derivative, which increases AMPK phosphorylation.

KL1333

KL1333 is an orally available, small organic molecule that reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mito-Lonidamine, Mito-LND supplier, Mitochondrial Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.